Blocking of angiotensin II is more than blocking of transforming growth factor-beta
- PMID: 18709023
- DOI: 10.1038/ki.2008.290
Blocking of angiotensin II is more than blocking of transforming growth factor-beta
Abstract
Fibrosis is a common feature of chronic kidney diseases that is mediated by matrix-producing myofibroblasts. One potential origin of myofibroblasts is epithelial-mesenchymal transition (EMT) of tubuloepithelial cells. Transforming growth factor-beta (TGF-beta) is a key factor inducing EMT. Carvajal et al. demonstrate that angiotensin II induces EMT by classical stimulation of TGF-beta and also by a TGF-beta-independent pathway, both signaling via Smad molecules. Therefore, blockade of angiotensin II is more than lowering of blood pressure and inhibition of TGF-beta stimulation.
Comment on
-
Angiotensin II activates the Smad pathway during epithelial mesenchymal transdifferentiation.Kidney Int. 2008 Sep;74(5):585-95. doi: 10.1038/ki.2008.213. Epub 2008 May 28. Kidney Int. 2008. PMID: 18509316
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources